Cite Filings / IRLA
Feed Companies Filings Check
Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Filings Financials Insiders Search text
All 475 Financials 116 Shareholder Meetings 13 Executive Compensation 100 Insider Trading 211 Beneficial Ownership Interest 66 Business Combinations 85 Public Offerings 29 Mutual Funds and ETFs 8 Others 48
›
Filed in
  1. No filings match these filters. Clear filters
  2. CORRESP Other Correspondence Between Filers and SEC Staff 2019-05-06
  3. CORRESP Other Correspondence Between Filers and SEC Staff 2019-04-29
  4. CORRESP Other Correspondence Between Filers and SEC Staff 2019-04-29
  5. S-1/A Offering Registration Statement 2019-04-29
  6. UPLOAD Other SEC-generated Letter 2019-04-25
  7. S-1/A Offering Registration Statement 2019-04-16
  8. CORRESP Other Correspondence Between Filers and SEC Staff 2019-04-12
  9. S-1 Offering Registration Statement 2019-04-12
  10. UPLOAD Other SEC-generated Letter 2019-04-02

Page 2 of 2 · 29 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…